AMTI - Applied Molecular Transport Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-15.11M

Cash

22.46M

Avg Qtr Burn

-18.8M

Short % of Float

2.15%

Insider Ownership

21.92%

Institutional Own.

44.51%

Qtr Updated

06/30/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
AMT-101 (IL-10 oral agonist) Details Pouchitis, Rheumatoid arthritis, Ulcerative colitis	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AMT-101 (IL-10 oral agonist) +anti-TNFα Details Rheumatoid arthritis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AMT-101 (IL-10 oral agonist) Details Ulcerative colitis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AMT-101 (IL-10 oral agonist) +anti-TNFα Details Ulcerative colitis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AMT-126 (IL-22) Details GI barrier repair	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.